CalciMedica, Inc.
CALCHealthcare|Biotechnology|US
$1.36
+0.06 (+4.62%)
DCF Value
$0.00
Tangible Book / Share
$1.61
Cash / Share
$5.44
About
CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tissue damage in these severe conditions. Their primary experimental drug, Auxora, is an intravenously administered, proprietary CRAC channel inhibitor being developed for the treatment of acute pancreatitis, including its asparaginase-associated form, and acute kidney injury.
Stock Price
-91.1%(1Y)
1M
+4.6%
3M
-60.5%
6M
-56.8%
YTD
-95.9%
1Y
-91.1%
3Y
-92.5%
5Y
-95.3%
Pipeline Summary
8 total trials1
Phase 1
8
Phase 2
0
Phase 3
0
Phase 4
Terminated: 2Completed: 4Recruiting: 1Withdrawn: 1
Active Trials (1)
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
NCT04195347Acute Pancreatitis
Phase 1Phase 2Recruiting
Enrollment: 42 participants
Key Facts
Market Cap$4.3M
Employees16 (+14% YoY)
CEOA. Rachel Leheny
IPO DateJun 14, 2023
Beta1.10
52-Week Range$1 – $36
Avg Volume76,981
ExchangeNASDAQ
Websitecalcimedica.com
Ownership
Float109.8%
Shares Outstanding3.1M
Recent Insider Trades
Roberts Eric WAWARD
Nov 3, 2026180,000 shares @ $1.47
Glicklich AlanAWARD
Oct 1, 202620,000 shares @ $1.64
Zaytsev EvgenyAWARD
Oct 1, 202620,000 shares @ $1.64
Guerard FredericAWARD
Oct 1, 202620,000 shares @ $1.64
Shaw AllanAWARD
Oct 1, 202620,000 shares @ $1.64
Peers
Recent News
CalciMedica to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference
Nov 3, 2026 · globenewswire.com
CalciMedica Inc. (NASDAQ:CALC) Stock Has Average Price Target of $50.00 According to Analysts
Oct 12, 2026 · defenseworld.net
CalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026 · globenewswire.com
CalciMedica Announces One-for-Five Reverse Stock Split
Aug 27, 2026 · globenewswire.com
Data last updated: Nov 9, 2026, 04:01 AM